Expert council resolution on the problem of diagnosis and treatment of resistant hypertension
On December 6, 2024, an Expert Council meeting was held in St. Petersburg on the problem of diagnosis and treatment of resistant hypertension (HTN). The importance of timely detection and treatment of patients with resistant hypertension is determined by a higher risk of myocardial infarction, stroke, heart failure and cardiovascular mortality compared to patients with uncontrolled HTN. The experts discussed the existing evidence base on a new class of aldosterone synthase inhibitors, in particular the baxdrostat.
Authors
- Sergey Vladimirovich Nedogoda (ORCID: https://orcid.org/0000-0001-5981-1754)
- А. И. Чесникова (ORCID: https://orcid.org/0000-0002-9323-592X)
- А. Yu. Falkovskaya (ORCID: https://orcid.org/0000-0002-5638-3034)
- А. S. Galyavich (ORCID: https://orcid.org/0000-0002-4510-6197)
- Е. И. Баранова (ORCID: https://orcid.org/0000-0002-8788-0076)
- Н. А. Козиолова (ORCID: https://orcid.org/0000-0001-7003-5186)
- А. О. Конради (ORCID: https://orcid.org/0000-0001-8169-7812)
- Н. Э. Звартау (ORCID: https://orcid.org/0000-0001-6533-5950)
Institutions
- Volgograd State Medical University (RU)
- Rostov State Medical University (RU)
- Kazan State Medical University (RU)
- First Pavlov State Medical University of St. Petersburg (RU)
- Federal Almazov North-West Medical Research Centre (RU)
- Perm State Medical Academy (RU)
- Tomsk National Research Medical Center (RU)
Publication Details
- Journal
- Russian Journal of Cardiology
- Published
- 2025-10-10
- DOI
- https://doi.org/10.15829/1560-4071-2025-6543
- Primary Topic
- Healthcare Systems and Public Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00